Aeglea Biotherapeutics shares owned by Rafferty Asset Management
Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Rafferty Asset Management
from 13F filings
Historical chart of Rafferty Asset Management investment in Aeglea Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Aeglea Biotherapeutics held by Rafferty Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Aeglea Biotherapeutics by Rafferty Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $1.0M | 60k | 16.76 |
| 2025-06-30 | $763k | 51k | 14.97 |
| 2025-03-31 | $1.1M | 70k | 16.14 |
| 2024-12-31 | $1.8M | 77k | 23.28 |
| 2024-09-30 | $2.1M | 71k | 29.41 |